Drug Shortage Report for AMPICILLIN SODIUM FOR INJECTION, USP
| Report ID | 260642 |
| Drug Identification Number | 01933353 |
| Brand name | AMPICILLIN SODIUM FOR INJECTION, USP |
| Common or Proper name | AMPICILLIN SODIUM INJ 2000MG |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | AMPICILLIN |
| Strength(s) | 2G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 PK |
| ATC code | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-06-18 |
| Estimated end date | 2026-03-20 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v20 | 2025-11-27 | French | Compare |
| v19 | 2025-11-27 | English | Compare |
| v18 | 2025-11-20 | French | Compare |
| v17 | 2025-11-20 | English | Compare |
| v16 | 2025-11-13 | French | Compare |
| v15 | 2025-11-13 | English | Compare |
| v14 | 2025-11-06 | French | Compare |
| v13 | 2025-11-06 | English | Compare |
| v12 | 2025-10-02 | French | Compare |
| v11 | 2025-10-02 | English | Compare |
| v10 | 2025-09-11 | French | Compare |
| v9 | 2025-09-11 | English | Compare |
| v8 | 2025-08-14 | French | Compare |
| v7 | 2025-08-14 | English | Compare |
| v6 | 2025-07-18 | French | Compare |
| v5 | 2025-07-18 | English | Compare |
| v4 | 2025-07-03 | French | Compare |
| v3 | 2025-07-03 | English | Compare |
| v2 | 2025-06-19 | French | Compare |
| v1 | 2025-06-19 | English | Compare |
Showing 1 to 20 of 20